Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Boudjeltia, Karim ^a   Faraut, Brice ^a   Esposito, Maria José ^a   Stenuit, Patricia ^a   Dyzma, Michal ^a   van Antwerpen, Pierre ^b   Brohée, Dany ^a   Vanhamme, Luc ^b   Moguilevsky, Nicole ^c   Vanhaeverbeek, Michel ^a   Kerkhofs, Myriam ^a  

^a CHU Andre Vesale   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; DISSOCIATION; ELECTROENCEPHALOGRAPHY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE COUNT; MALE; NIGHT SLEEP; NORMAL HUMAN; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP DEPRIVATION; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SLOW WAVE SLEEP;

ADULT; C-REACTIVE PROTEIN; FIBRINOGEN; HEALTH; HUMANS; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-8; LEUKOCYTES; LIPOPROTEINS, LDL; MALE; PEROXIDASE; SLEEP; SLEEP DEPRIVATION; TIME FACTORS; YOUNG ADULT;

EID: 82355183889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028230     Document Type: Article

References (40)

1. National Sleep Foundation, 2009 Sleep in America poll, 2009 Available from: <;http://www.sleepfoundation.org/sites/default/files/2009%20Sleep%20in%20America%20SOF%20EMBARGOED.pdf>.
2. Gallicchio L, Kalesan B, (2009) Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res 18: 148-158.
3. Van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, et al. (2009) Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. Plos One 4: e4589.
4. Faraut B, Boudjeltia KZ, Dyzma M, Rousseau A, David E, et al. (2011) Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction. Brain Behav Immun 25: 16-24.
5. Tsimikas S, (2008) In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol 101: 34D-42D.
6. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, et al. (2004) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296: 2391-2394.
7. Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, et al. (2004) Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 37: 902-11.
8. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, et al. (2008) Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 124: 319-25.
9. Rechtschaffen A, Kales A, eds. (1968) A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects Los Angeles Brain Information Service/Brain Research Institute, UCLA.
10. King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, et al. (2008) Short sleep duration and incident coronary artery calcification. JAMA 300: 2859-66.
11. Heslop P, Davey Smith G, Metcalfe C, MacLeod J, Hart C, (2002) Sleep duration and mortality: the effects of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 3: 305-14.
12. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M, (2011) Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev Aug 9 Epub ahead of print.
13. Zalokar JB, Richard JL, Claude JR, (1981) Leukocyte count, smoking and myocardial infarction. N Engl J Med 304: 465-468.
14. Olivares R, Ducimetière P, Claude JR, (1993) Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 137: 49-53.
15. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, et al. (2005) Intermountain Heart Collaborative Study GroupWhich white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45: 1638-1643.
16. Kerkhofs M, Zouaoui Boudjeltia K, Stenuit P, Brohée d, Cauchie P, et al. (2007) Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in posmenopausal women: a preliminary study. Maturitas 56: 212-215.
17. Zouaoui Boudjeltia K, Faraut B, Stenuit P, Esposito MJ, Dyzma M, et al. (2008) Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: a pilot study. Vascular Health Risk Manag 4: 1467-1470.
18. Lange T, Born J, (2011) The immune recovery function of sleep- tracked by neutrophil counts. Brain Behav Immun 25: 14-5.
19. Haack M, Sanchez E, Mullington JM, (2007) Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30: 1145-52.
20. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, et al. (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43: 678-83.
21. Frey DJ, Fleshner M, Wright KP Jr, (2007) The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav Immun 21: 1050-1057.
22. Haack M, Kraus T, Schuld A, Dalal M, Koethe D, et al. (2002) Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology 27: 921-931.
23. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, et al. (2001) Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47: 426-30.
24. Larsson A, Carlsson L, Axelsson J, (2008) Low diurnal variability of apolipoprotein A1, apolipoprotein B and apolipoprotein B/apolipoprotein A1 ratio during normal sleep and after an acute shift of sleep. Clin Biochem 41: 859-62.
25. Oscarsson J, Lundstam U, Gustafsson B, Wilton P, Edén S, et al. (1995) Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol (Oxf) 42: 673-6.
26. Moguilevsky N, Zouaoui Boudjeltia K, Babar S, Delrée P, Legssyer I, et al. (2004) Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. Biochem Biophys Res Commun 323: 1223-8.
27. Zouaoui Boudjeltia K, Moguilevsky N, Legssyer I, Babar S, Guillaume M, et al. (2004) Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem Biophys Res Commun 325: 434-8.
28. Bleeke T, Zhang H, Madamanchi N, Patterson C, Faber JE, (2004) Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45.
29. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M, (1999) Effects of sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 84: 1979-85.
30. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, et al. (2008) Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 118: 75-83.
31. Spiegel K, Leproult R, Colecchia EF, L'Hermite-Balériaux M, Nie Z, et al. (2000) Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am J Physiol Regul Integr Comp Physiol 279: R8746-883.
32. Veldhuis JD, Iranmanesh A, (1996) Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 19: S221-4.
33. Heemskerk VH, Daemen M, Buurman WA, (1999) Insulin-like growth factor (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev 10: 5-14.
34. Bjerknes R, Aarskog D, (1995) Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor I: increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst. J Clin Endocrinol Metab 80: 1948-55.
35. van Leeuwen WM, Hublin C, Sallinen M, Härmä M, Hirvonen A, et al. (2010) Prolonged sleep restriction affects glucose metabolism in healthy young men. Int J Endocrinol 2010: 108641.
36. Tsimikas S, Willerson JT, Ridker PM, (2006) C-reactive protein and other emerging biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 18: C19-31.
37. Van Antwerpen P, Slomianny M-C, Zouaoui Boudjeltia K, Delporte C, Faid V, et al. (2010) Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity. J Biol Chem 285: 16351-59.
38. Calay D, Rousseau A, Mattart L, Nuyens V, Delporte C, et al. (2010) Copper and myeloperoxidase-modified LDLs activate Nrf2 through different pathways of ROS production in macrophages. Antioxid Redox Sign 13: 1491-1502.
39. Irwin MR, Carrillo C, Olmstead R, (2010) Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun 24: 54-7.
40. Miller MA, Kandala NB, Kivimaki M, Kumari M, Brunner EJ, et al. (2009) Gender differences in the cross-sectional relationship between sleep duration and markers of inflammation: Whitehall II study. Sleep 32: 857-864.